leadf
logo-loader
viewSativa Wellnesss Group Inc

Sativa Investments 'at the forefront' of developing UK medical cannabis market

Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London's Andrew Scott to discuss the NEX-based medical cannabis investor's trading and strategic update.

Sativa's this week unveiled plans to become a first-mover seed-to-consumer business in the UK.

The firm's taking its cue from Canada, which first approved the drug for medical use 18 years ago, and is now home to vertically integrated cannabis giants such as Canopy Growth (now listed in New York and worth around US$10bn).

Quick facts: Sativa Wellnesss Group Inc

Price: 4.25 GBX

AQSE:SWEL
Market: AQSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Wellnesss Group Inc named herein, including the promotion by the Company of Sativa Wellnesss Group Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Sativa completes merger with StillCanna, changes name to Sativa Wellness...

Sativa Wellness Group (CSE: SWEI-AQSE: SWEL) CEO Henry Lees-Buckley joined Steve Darling from Proactive to update the merger between Sativa and StillCanna. Lees-Buckley telling Proactive about the new company and how things will work. He also talks about its core brand Goodbody and how...

on 1/10/20

2 min read